Completed NA INTERVENTIONAL 2-arm NCT00187187

DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) (DAVIDII)

Sponsor: Abbott Medical Devices

Conditions Congestive Heart Failure Sudden Cardiac Death Ventricular Fibrillation Ventricular Tachycardia

Interventions Implantable Defibrillator (ICD)

Updated 8 times since 2017 Last updated: Feb 1, 2019 Started: Jun 30, 2003 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00187187, this NA trial focuses on Congestive Heart Failure and Sudden Cardiac Death and remains completed. Sponsored by Abbott Medical Devices, it has been updated 8 times since 2003, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA
Feb 2019 — Mar 2019 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices
University of Washington

Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.